Jan 20, 2021: Industry insights
The global mycoplasma testing market was valued at USD 446.9 million in 2016 and is anticipated to witness a lucrative growth over the forecast period. Rising number of pharmaceutical and biopharmaceutical companies, increasing R&D investment, and growing number of drug launches are major attributes that are fuelling the market.
Increase in the number of biopharmaceutical and pharmaceutical companies has been seen in the past years. This growth has been attributed by the need for advanced drugs and therapies for the treatment of chronic diseases like cancer, diabetes, cardiovascular diseases and osteoporosis among others. The research work is supported by the government by funding the pharmaceutical and biotechnology companies in order to facilitate research based activities for the development of new drugs. This may foster the growth of mycoplasma testing market.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/mycoplasma-testing-market/request-sample
Rising investment in R&D by dominant players has further resulted in growth of the market. In the year 2016, North America spent 28.4% of its GDP on research and development according to Global R&D Funding Forecast. This signifies significant rise in the spending by various companies for the invention of new and enhanced testing devices and kits. With the growing expenditure by the government in the healthcare industry and awareness campaigns have led to the growth of the mycoplasma testing market. Mycoplasma testing is conducted so as to ensure the product is contamination free during each stage of manufacturing process.
Mycoplasma contamination is a major cause of concern in research and development activities. Infections caused by M. orale or M. fermentans are strains that frequently are seen in humans are a key source of contamination in laboratory settings. These contaminations in cell cultures cause morphological changes, altered cell metabolism and chromosomal aberrations causing contamination in the entire cell line. Contamination may also result in serious complications such as pneumonia, genital infections and other respiratory disorders is also seen. Thus, to prevent such contaminations, mycoplasma testing is vital.
Access This Full Report @ https://www.millioninsights.com/industry-reports/mycoplasma-testing-market
Product Insights
Based on the products, the market is segmented into kits, reagents, instruments, and services. Kits & reagents segment holds the largest market share owing to its repetitive purchase. Kits & reagents segment has been studied after further sub-segmentation into- nucleic acid detection kits, elimination kits, PCR assays, stains, and standards & controls.
Instruments segment is projected to show a lucrative growth in the forecast period owing to introduction of advanced automated machines for detection of mycoplasma contamination. The results obtained are fast and highly efficient.
Technology Insights
On the basis of technology, PCR segment held the largest share in 2016. PCR helps to detect the mycoplasma using its double stranded DNA. The DNA of the mycoplasma are amplified, and then a dye is used which attaches to the DNA and emits light. This shows the presence of mycoplasma.
Microbial culture is expected to show lucrative growth over the forecast period. The increasing number of research activities in academics, research laboratories, pharmaceutical and biopharmaceutical companies is supporting the growth.
Application Insights
On the basis of application, cell line testing held the largest share in 2016. Cell line testing is generally conducted in the laboratory and is the major source of mycoplasma contamination. This segment is expected to show growth over the forecast period due to increasing application of mycoplasma testing to avoid contamination in the cell culture.
End of production cells is projected to show lucrative growth over the forecast period due to the increase in clinical trials for drug discovery and development. The quality control taken in the drug discovery is majorly contributing to the of this segment share.
End-use Insights
On the basis of end use, pharmaceutical and biotechnology companies contributed towards the largest share in 2016. The government’s support along with the huge investment made by these companies in the R&D activities has led to the development new drugs which in turn has contributed to the growth of the market.
Contract research organisations are projected to show attractive growth over the forecast period because large number of research activities is conducted by these organisations which are outsourced by the pharmaceutical and biotechnology companies.
Regional Insights
North America dominated the market in 2016 owing to the rising healthcare expenditure made by the US government in R&D activities for the development of new drugs. There is also spending on healthcare infrastructure which contributes to the growth.
Asia Pacific region is projected to show a lucrative growth over the forecast period owing to increasing awareness and funding initiatives undertaken by the government for the development of new drugs.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Spectroscopy is the interaction between electromagnetic radiation and the matter.
Properties of process spectroscopy like cost-effectiveness and time saving are stimulating the demand for the technique, thereby encouraging process spectroscopy industry.
Download Free Sample Report @ https://www.millioninsights.com/industry-reports/process-spectroscopy-market/request-sample However, lack of skilled labor followed by significant initial investment is expected to obstruct the market growth of process spectroscopy.
Process spectroscopy market is witnessing opportunities from modernizations in spectroscopic domain since it decreases the total expenditure of product investigation and marketing by manufacturers.
On the basis of technology, the market is divided into Raman spectroscopy, infrared (NIR) spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, etc.
In the previous years, pharmaceutical industry led process spectroscopy industry followed by agriculture and food.
The global Perfusion System Market size is expected to value at USD 183.8 million by 2025.
Globally, the perfusion system market is predicted to grow at a CAGR of 8.7% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.However, limited supply of resources is one of the prominent factor restraining market growth, in the recent years.
Yet, recent innovation such as Machine Perfusion (MP) and Static Cold Storage (SCS) that are widely used as the preservation methods, are helping to curb this issue.
Static Cold Storage (SCS) are increasingly adopted for preservation of organs, yet, they are incompetent to store high-risk organs.
Higher success rates associated with these treatments in the recent years is estimated to boost the growth of perfusion system industry.However, decline in number of organ donors are resulting in shortage in numerous medical facilities across the globe, thus hampering market growth to certain extent.
Large number of benefits associated with early adoption of Hypothermic Machine Perfusion (HMP) such as kidney preservation alongside a cold storage, are offering required level safety and improved shelf life of an organ before transplantation procedure.During surgical procedure such as kidney transplant surgery, it aids in aggregating patient survival rate and overall success rate of the surgical procedure performed worldwide.
